![Emeritus Professor Sue Tett](/sites/default/files/profiles/480.jpeg)
Overview
Background
Professor Susan Tett is a registered pharmacist with research interests in Quality Use of Medicines (improving how medicines are used) and clinical pharmacokinetics (optimising medicine doses)
Sue completed her PhD in 1988. Since this time she has been in research positions and in academia at Sydney University, St Vincent’s Hospital, Sydney and at the University of Queensland. She has over 150 peer reviewed research publications and over 200 conference presentations and is on Editorial Board of Clinical Pharmacokinetics. Sue was Head of the School of Pharmacy, University of Queensland 1996-2004 and Deputy Executive Dean & Associate Dean Research for the Faculty of Health Sciences 2006-2010, including periods as Acting Executive Dean.
Susan Tett has been a member of many Australian national and State advisory committees, including Pharmaceutical Health and Rational use of Medicines Committee 1996-2004, Pharmaceutical Sub-Committee of the Australian Drug Evaluation Committee 1995-2004, Pharmaceutical Industry Working Group 2003-10 , Pharmaceutical Partnerships Program Committee of the Industry Research & Development Board 2003-09, and has participated in NHMRC Project Grant Review Panels and Fellowships Panels. She was also Councillor for the Pharmaceutical Society of Australia (Queensland Branch) and was the Australian Pharmacist of the Year in 1999, for her contributions to pharmacy education and research.
Sue’s research interests are directed towards optimising the clinical use of medications. General areas of research include quality use of medicines, clinical pharmacokinetics and pharmacodynamics. Sue supervises a number of postgraduate students and is actively involved in innovation in the pharmacy profession, pushing the professional boundaries. She is committed to enhancing the role of the health care team in optimising consumer health outcomes.
Availability
- Emeritus Professor Sue Tett is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor (Honours), University of Sydney
- Doctor of Philosophy, University of Sydney
Research interests
-
Clinical pharmacokinetics and pharmacodynamics
Many projects being undertaken to define better dosing options to give improved patient outcomes - eg. in people who have received organ transplants (tacrolimus, mycophenolate, sirolimus) or who need other immunosuppressants (eg. leflunomide in people with rheumatoid arthritis).
-
Quality use of Medicines
Numerous projects designed to improve how medicines are used - particular interests in health care teams, including consumers; rural health; medication use and misuse and international comparisons of prescription medication use
Works
Search Professor Sue Tett’s works on UQ eSpace
1992
Journal Article
Bioavailability of Hydroxychloroquine Tablets Assessed with Deconvolution Techniques
Tett, SE, Cutler, DJ and Day, RO (1992). Bioavailability of Hydroxychloroquine Tablets Assessed with Deconvolution Techniques. Journal of Pharmaceutical Sciences, 81 (2), 155-159. doi: 10.1002/jps.2600810211
1991
Journal Article
High-Performance Liquid-Chromatographic Separation of the Enantiomers of Hydroxychloroquine and its Major Metabolites in Biological-Fluids Using An Alpha-1-Acid Glycoprotein Stationary Phase
McLachlan, AJ, Tett, SE and Cutler, DJ (1991). High-Performance Liquid-Chromatographic Separation of the Enantiomers of Hydroxychloroquine and its Major Metabolites in Biological-Fluids Using An Alpha-1-Acid Glycoprotein Stationary Phase. Journal of Chromatography-Biomedical Applications, 570 (1), 119-127. doi: 10.1016/0378-4347(91)80206-R
1990
Journal Article
Antimalarials in Rheumatic Diseases
Tett, S, Cutler, D and Day, R (1990). Antimalarials in Rheumatic Diseases. Baillieres Clinical Rheumatology, 4 (3), 467-489. doi: 10.1016/S0950-3579(05)80004-4
1990
Conference Publication
Hydroxychloroquine Concentrations and Clinical Effects in Rheumatoid-Arthritis Patients
Tett, SE, Cutler, DJ and Day, RO (1990). Hydroxychloroquine Concentrations and Clinical Effects in Rheumatoid-Arthritis Patients. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/0014-2999(90)92892-M
1989
Journal Article
Bioavailability of Hydroxychloroquine Tablets in Healthy-Volunteers
Tett, SE, Cutler, DJ, Day, RO and Brown, KF (1989). Bioavailability of Hydroxychloroquine Tablets in Healthy-Volunteers. British Journal of Clinical Pharmacology, 27 (6), 771-779. doi: 10.1111/j.1365-2125.1989.tb03439.x
1988
Journal Article
A Dose-Ranging Study of the Pharmacokinetics of Hydroxychloroquine Following Intravenous Administration to Healthy-Volunteers
Tett, SE, Cutler, DJ, Day, RO and Brown, KF (1988). A Dose-Ranging Study of the Pharmacokinetics of Hydroxychloroquine Following Intravenous Administration to Healthy-Volunteers. British Journal of Clinical Pharmacology, 26 (3), 303-313. doi: 10.1111/j.1365-2125.1988.tb05281.x
1987
Journal Article
Apparent Dose-Dependence of Chloroquine Pharmacokinetics Due to Limited Assay Sensitivity and Short Sampling Times
Tett, SE and Cutler, DJ (1987). Apparent Dose-Dependence of Chloroquine Pharmacokinetics Due to Limited Assay Sensitivity and Short Sampling Times. European Journal of Clinical Pharmacology, 31 (6), 729-731. doi: 10.1007/BF00541305
1986
Journal Article
Removal of An Endogenous Fluorescent Compound From Urine to Allow Quantitation of Low Concentrations of Hydroxychloroquine and Metabolites by High-Performance Liquid-Chromatography
Tett, SE, Cutler, DJ and Brown, KF (1986). Removal of An Endogenous Fluorescent Compound From Urine to Allow Quantitation of Low Concentrations of Hydroxychloroquine and Metabolites by High-Performance Liquid-Chromatography. Journal of Chromatography, 383 (1), 236-238. doi: 10.1016/S0378-4347(00)83468-4
1985
Journal Article
High-Performance Liquid-Chromatographic Assay for Hydroxychloroquine and Metabolites in Blood and Plasma, Using a Stationary Phase of Poly(styrene Divinylbenzene) and a Mobile Phase At Ph 11, with Fluorimetric Detection
Tett, SE, Cutler, DJ and Brown, KF (1985). High-Performance Liquid-Chromatographic Assay for Hydroxychloroquine and Metabolites in Blood and Plasma, Using a Stationary Phase of Poly(styrene Divinylbenzene) and a Mobile Phase At Ph 11, with Fluorimetric Detection. Journal of Chromatography, 344 (NOV), 241-248. doi: 10.1016/S0378-4347(00)82024-1
Funding
Past funding
Supervision
Availability
- Emeritus Professor Sue Tett is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Towards optimal dosing of new immunosuppressant drugs in solid organ transplants
Improving dosing of immunosuppressant medications in people who have received solid organ transplants. Studies with tacrolimus, mycophenolate or sirolimus can be offered
-
International comparisons of medicines use, investigating pharmaceutical policy and other influences on usage
International comparisons of the use of prescription medicines are important to improve the quality use of medicines across different jurisdictions. Lessons learned from one area can be translated into interventions to be applied to improve medicine use across a number of different health care systems
-
Factors affecting prescribing and use of medicines, including the influence of various marketing strategies (eg. free prescription medicine samples), the influence of location (eg. rural, remote) and
Many factors are know to affect prescribing and use of medicines. Projects in this area will be designed to investigate specific aspects of these factors eg. effects of remote location, influence of free sample medications etc etc
-
Drug usage evaluation across different jurisdictions
Drug usage evaluation, including the feedback, intervention and re-evaluation stages can influence how medicines are prescribed and used. Multicentre studies can have wide ranging influence, and studies across several jurisdictions (eg. hospital/community; public/private) can influence quality use of medicines in sustainable ways across large geographical areas. Projects are offered in the areas, particularly focussing on multi-disciplinary teams and multi-jurisdictional influences
-
Population Pharmacokinetics and Pharmacodynamics of the Newer Immunosuppressant Drug
Supervision history
Completed supervision
-
2009
Doctor Philosophy
Geographical differences, national and international, in the utilization of the benzodiazepine and antidepressant groups of medicines
Principal Advisor
Other advisors: Emeritus Professor Wayne Hall
-
2007
Doctor Philosophy
CONVENTIONAL MEDICINE AND COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) - CONCORDANCE AND PERSPECTIVES OF CONSUMERS, HEALTH PROFESSIONALS AND CAM PRACTITIONERS
Principal Advisor
-
2005
Doctor Philosophy
Use of leflunomide in rheumatoid arthritis
Principal Advisor
-
2004
Doctor Philosophy
Pharmacokinetic studies with sirolimus and tacrolimus
Principal Advisor
-
2002
Doctor Philosophy
POPULATION PHARMACOKINETICS AND PHARMOCODYNAMICS OF THE NEW IMMUNOSUPRESSANT DRUGS
Principal Advisor
-
2002
Doctor Philosophy
QUALITY USE OF MEDICINES: FROM DUE TO RURAL COMMUNITY PHARMACY PRACTICE
Principal Advisor
Other advisors: Emeritus Professor Maree Smith
-
2021
Doctor Philosophy
Evaluating Prediction Methods for Estimating Tacrolimus, Mycophenolate and Prednisolone Exposure Following Adult Kidney Transplantation
Associate Advisor
Other advisors: Dr Christine Staatz
-
2016
Doctor Philosophy
Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
Associate Advisor
Other advisors: Dr Christine Staatz
-
2009
Doctor Philosophy
Prescription medicine samples and therapy initiation. Developing a best practice system with community pharmacists in Australia
Associate Advisor
Other advisors: Professor Lisa Nissen
-
2007
Doctor Philosophy
Optimising the assesssment of renal function and determining the renal elimination of drugs using various methodologies
Associate Advisor
Media
Enquiries
Contact Emeritus Professor Sue Tett directly for media enquiries about:
- Clinical pharmacokinetics
- Clinical pharmacy
- Medicine - quality use of
- Pharmacokinetics
- Pharmacy - clinical
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: